Vico Therapeutics
Developer of modulating therapies designed for patients suffering from severe neurological disorders. The company's initial focus is on spinocerebellar ataxia which is a subgroup of hereditary ataxia,...
Valuation
$0
Share Price
N/A
Total Raised
$101.4M
Last Round
N/A